Published • loading... • Updated
K-Medihub Support, Clickless Selected for Deferral of New Medical Technology Evaluation
Summary by 매일신문
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
K-Medihub (Daegu Gyeongbuk Advanced Medical Industry Promotion Foundation) announced on the 2nd that 'Clickless,' a digital therapeutic device for temporomandibular joint disorder (TMD) that it supported from research and development to commercialization, has been included in the list of devices eligible for a deferral of the New Medical Technology Evaluation. Clickless, developed by Beyond Medicine, was selected for the New Medical Technology …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
